(2019)
ApoE attenuates unresolvable inflammation by complex formation with activated C1q.
Nat Med 25(3),
496-506.
Prof. Dr. Christine Skerka
AlumniPublikationen
(2019)
C3-glomerulopathy autoantibodies mediate distinct effects on complement C3- and C5-convertases.
Front Immunol 10,
1030.
(2019)
Complement inhibitors in clinical trials for glomerular diseases.
Front Immunol 10,
2166.
(Review)
(2018)
Aspf2 from Aspergillus fumigatus recruits human immune regulators for immune evasion and cell damage.
Front Immunol 9,
1635.
(2018)
Playing 'hide-and-seek' with factor H: game-theoretical analysis of a single nucleotide polymorphism.
J R Soc Interface 15(142),
20170963.
(2018)
Kallikrein cleaves C3 and activates complement.
J Innate Immun 10(2),
94-105.
(2018)
The secreted Candida albicans protein Pra1 disrupts host defense by broadly targeting and blocking complement C3 and C3 activation fragments.
Mol Immunol 93,
266-277.
(2018)
Streptococcus pneumoniae from patients with hemolytic uremic syndrome binds human plasminogen via the surface protein PspC and uses plasmin to damage human endothelial cells.
J Infect Dis 217(3),
358-370.
(2018)
The MFHR1 fusion protein is a novel synthetic multitarget complement inhibitor with therapeutic potential.
J Am Soc Nephrol 29(4),
1141-1153.
(2018)
Evaluation of serum sphingolipids and the influence of genetic risk factors in age-related macular degeneration.
PLOS One 13(8),
e0200739.